{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T10:44:19Z","timestamp":1774521859833,"version":"3.50.1"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,9,1]]},"DOI":"10.2169\/internalmedicine.3065-23","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T22:15:55Z","timestamp":1706739355000},"page":"2433-2437","source":"Crossref","is-referenced-by-count":1,"title":["Successful Treatment of Malignant Lymphoma Following Transcatheter Aortic Valve Replacement"],"prefix":"10.2169","volume":"63","author":[{"given":"Takumi","family":"Osawa","sequence":"first","affiliation":[{"name":"Department of Cardiology, Institute of Medicine, University of Tsukuba, Japan"},{"name":"Department of Cardiology, Tsukuba Medical Center Hospital, Japan"},{"name":"Department of Cardiology, National Cancer Center Hospital East, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuko","family":"Tajiri","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Cancer Center Hospital East, Japan"},{"name":"Tsukuba Life Science Innovation Program (T-LSI), School of Integrative and Global Majors (SIGMA), University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Hoshi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ieda","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Ishizu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute of Medicine, University of Tsukuba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Thieblemont C, Coiffier B. Lymphoma in older patients. J Clin Oncol 25: 1916-1923, 2007.","DOI":"10.1200\/JCO.2006.10.5957"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Azim HA, Santoro L, Bociek RG, Gandini S, Malek RA, Azim HA Jr. High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis. Ann Oncol 21: 1064-1071, 2010.","DOI":"10.1093\/annonc\/mdp425"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Schmittlutz K, Marks R. Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologist. Ther Adv Hematol 12: 2040620721996484, 2021.","DOI":"10.1177\/2040620721996484"},{"key":"4","unstructured":"4. Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, et al.; ESC Scientific Document Group. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 43: 4229-4361, 2022."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 70: 252-289, 2017.","DOI":"10.1016\/j.jacc.2017.03.011"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38: 2739-2791, 2017.","DOI":"10.1093\/eurheartj\/ehx470"},{"key":"7","unstructured":"7. Dall'Ara G, Saia F, Moretti C, et al. Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty. Catheter Cardiovasc Interv 89: E145-152, 2017."},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Swift SL, Puehler T, Misso K, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis. BMJ Open 11: e054222, 2021.","DOI":"10.1136\/bmjopen-2021-054222"},{"key":"9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/1471-2407-13-519","volume":"13","author":"CA Pinto","year":"2013","unstructured":"9. Pinto CA, Marcella S, August DA, Holland B, Kostis JB, Demissie K. Cardiopulmonary bypass has a modest association with cancer progression: a retrospective cohort study. BMC Cancer 13: 519, 2013.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lerman TT, Levi A, J\u00f8rgensen TH, S\u00f8ndergaard L, Talmor-Barkan Y, Kornowski R. Comparison of middle-term valve durability between transcatheter aortic valve implantation and surgical aortic valve replacement: an updated systematic review and meta-analysis of RCTs. Front Cardiovasc Med 10: 1242608, 2023.","DOI":"10.3389\/fcvm.2023.1242608"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Izumi C, Eishi K, Ashihara K, et al.; the Japanese Circulation Society Joint Working Group. JCS\/JSCS\/JATS\/JSVS 2020 Guidelines on the Management of Valvular Heart Disease. Circ J 84: 2037-2119, 2020.","DOI":"10.1253\/circj.CJ-20-0135"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Brouwer J, Nijenhuis VJ, Delewi R, et al. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med 383: 1447-1457, 2020.","DOI":"10.1056\/NEJMoa2017815"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ahmad Y, Howard JP, Madhavan MV, Leon MB, Makkar RR. Single versus dual antiplatelet therapy after transcatheter aortic valve replacement: a meta-analysis of randomized clinical trials. Cardiovasc Revasc Med 34: 46-53, 2022.","DOI":"10.1016\/j.carrev.2021.01.016"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lin X, Wang S, Wang L, Guan Y, Huang J. Aspirin alone versus dual antiplatelet therapy after transcatheter aortic valve replacement: a systematic review and meta-analysis. Cardiovasc Drugs Ther 36: 271-278, 2022.","DOI":"10.1007\/s10557-021-07145-7"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kobari Y, Inohara T, Tsuruta H, et al. No antithrombotic therapy after transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry. JACC Cardiovasc Interv 16: 79-91, 2023.","DOI":"10.1016\/j.jcin.2022.10.010"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Carver JR, Shapiro CL, Ng A, et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 25: 3991-4008, 2007.","DOI":"10.1200\/JCO.2007.10.9777"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. von Hoff DD, Layard MW, Basa P, et al. Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91: 710-717, 1979.","DOI":"10.7326\/0003-4819-91-5-710"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tajiri K, Sekine I, Naito H, et al. Cardiology consultation in oncology practice: a 5-year survey. Jpn J Clin Oncol 50: 1419-1425, 2020.","DOI":"10.1093\/jjco\/hyaa118"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tajiri K, Aonuma K, Sekine I. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients. Jpn J Clin Oncol 47: 678-682, 2017.","DOI":"10.1093\/jjco\/hyx068"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/17\/63_3065-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T03:34:36Z","timestamp":1725680076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/17\/63_3065-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":19,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3065-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,1]]},"article-number":"3065-23"}}